Liminal Biosciences Inc (LMNL)
8.50
0.00 (0.00%)
USD |
NASDAQ |
Sep 26, 16:00
Liminal Biosciences Free Cash Flow (Quarterly): -5.827M for June 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -5.827M |
| March 31, 2023 | -7.644M |
| December 31, 2022 | -4.913M |
| September 30, 2022 | -8.730M |
| June 30, 2022 | -5.265M |
| March 31, 2022 | -5.565M |
| December 31, 2021 | -10.53M |
| September 30, 2021 | -44.88M |
| June 30, 2021 | -7.637M |
| March 31, 2021 | -16.77M |
| December 31, 2020 | -19.93M |
| September 30, 2020 | -14.59M |
| June 30, 2020 | -5.853M |
| March 31, 2020 | -17.81M |
| December 31, 2019 | -26.63M |
| September 30, 2019 | -14.12M |
| June 30, 2019 | -23.37M |
| March 31, 2019 | -14.11M |
| December 31, 2018 | -20.96M |
| September 30, 2018 | -9.861M |
| June 30, 2018 | -10.22M |
| March 31, 2018 | -26.54M |
| December 31, 2017 | -20.68M |
| September 30, 2017 | -30.94M |
| June 30, 2017 | -21.60M |
| Date | Value |
|---|---|
| March 31, 2017 | -29.14M |
| December 31, 2016 | -26.65M |
| September 30, 2016 | -18.88M |
| June 30, 2016 | -21.98M |
| March 31, 2016 | -17.99M |
| December 31, 2015 | -11.41M |
| September 30, 2015 | -9.209M |
| June 30, 2015 | -14.68M |
| March 31, 2015 | -5.893M |
| December 31, 2014 | -9.292M |
| September 30, 2014 | -7.912M |
| June 30, 2014 | -7.613M |
| March 31, 2014 | -6.865M |
| December 31, 2013 | -11.43M |
| September 30, 2013 | -7.203M |
| June 30, 2013 | -2.032M |
| March 31, 2013 | -3.265M |
| December 31, 2012 | 0.3784M |
| September 30, 2012 | -0.2402M |
| June 30, 2012 | -1.282M |
| March 31, 2012 | -1.744M |
| December 31, 2011 | -1.171M |
| September 30, 2011 | -1.698M |
| June 30, 2011 | -3.224M |
| March 31, 2011 | -2.390M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-44.88M
Minimum
Sep 2021
-4.913M
Maximum
Dec 2022
-14.48M
Average
-14.11M
Median
Mar 2019
Free Cash Flow (Quarterly) Benchmarks
| Acasti Pharma Inc | -2.113M |
| Aurinia Pharmaceuticals Inc | -13.20M |
| Edesa Biotech Inc | -1.805M |
| Lexaria Bioscience Corp | -1.690M |
| Xenon Pharmaceuticals Inc | -43.43M |